Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-01

Clinical Trial Update: Efficacy and Safety of Inhaled Insulin Compared to Metformin and Glimepiride in Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing inhaled insulin to metformin and glimepiride in type 2 diabetes was terminated; the update discusses the efficacy and safety observati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glimepiride (glimepiride)
  • Inhaled insulin (insulin)
  • metformin (metformin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: TERMINATED